Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study. [electronic resource]
Producer: 20120913Description: 613-8 p. digitalISSN:- 1460-2385
- Adult
- Amides -- adverse effects
- Antihypertensive Agents -- adverse effects
- Confidence Intervals
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Fumarates -- adverse effects
- Glomerulonephritis, IGA -- diagnosis
- Hong Kong
- Humans
- Interleukin-6 -- analysis
- Kidney Function Tests
- Losartan -- adverse effects
- Male
- Middle Aged
- Odds Ratio
- Pilot Projects
- Prospective Studies
- Proteinuria -- prevention & control
- Risk Assessment
- Severity of Illness Index
- Time Factors
- Transforming Growth Factor beta -- analysis
- Treatment Outcome
- Urinalysis
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.